Studies of depression and hepatitis C virus (HCV) infection in HIV-infected patients have been contradictory and often not addressed key differences between HCV-infected and uninfected individuals including substance use. This cross-sectional observational study from the University of Washington HIV cohort examined associations between HCV, symptoms, and depression in HIV-infected patients in routine clinical care. Patients completed instruments measuring depression, symptoms, and substance use. We generated depression severity scores and used linear regression to examine the relationship with HCV accounting for demographic and clinical characteristics. We conducted sensitivity analyses in which we removed depression somatic symptom items (e.g., fatigue) from depression scores, and sensitivity analyses in which we also adjusted for nondepression somatic symptom items to examine the role of somatic and nonsomatic symptoms in the association between depression and HCV. Of 764 HIV-infected patients, 160 (21%) were HCV-infected. In adjusted analysis, HCV-infected patients had worse depression severity (p 0 0.01) even after adjusting for differences in substance use. HCV remained associated with depression severity in secondary analyses that omitted the depression somatic patient health questionnaire-9 (PHQ-9) items (p 00.01). However, when nondepression somatic symptoms were included as covariates in multivariate analyses, HCV was no longer associated with depression (p 00.09).
Introduction
Understanding the connection between hepatitis C virus (HCV) infection and depression in HIV-infected patients is critical given the effect of depression on quality of life, adherence to antiretroviral therapy, and the decision to initiate HCV treatment (Braitstein et al., 2005; Buti, Wong, Casado, & Esteban, 2006; Fleming et al., 2004; Kanwal et al., 2005; Starace et al., 2002) . In the United States, HCV infection is more common among HIV-infected than among uninfected individuals, with a reported prevalence rate ranging between 16% and 37% (Kim, Psevdos, Suh, & Sharp, 2008; Sherman, Rouster, Chung, & Rajicic, 2002; Staples, Rimland, & Dudas, 1999) . Previous studies examining the occurrence of depressive symptoms in patients coinfected with HIV and HCV have produced conflicting results, with some finding an association (Backus, Boothroyd, & Deyton, 2005; Baum et al., 2008; Libman et al., 2006; Mrus et al., 2006) and others not (Baillargeon et al., 2008; Grassi et al., 2002; Richardson et al., 2005; Ryan, Morgello, Isaacs, Naseer, & Gerits, 2004; Thein et al., 2007; von Giesen, Heintges, Abbasi-Boroudjeni, Kucukkoylu, Koller, & Haslinger, 2004) . These different results might be explained by confounding factors, the use of different depression scales, small samples, and variable prevalence of HCV treatment that can itself precipitate depression. Compared with HIV-infected patients without HCV, HIV and HCV coinfected individuals tend to be older (Backus et al., 2005; Kanwal et al., 2005; Mrus et al., 2006; Staples et al., 1999; Sulkowski, Moore, Mehta, Chaisson, & Thomas, 2002) , more likely to be male (Backus et al., 2005; Kanwal et al., 2005; Kim et al., 2008) , African-American (Kanwal et al., 2005; Kim et al., 2008; Staples et al., 1999; Sulkowski et al., 2002) or Hispanic (Backus et al., 2005) , and to have a history of alcohol abuse or illicit drug use (Backus et al., 2005; Kanwal et al., 2005; Kim et al., 2008; Staples et al., 1999; Sulkowski et al., 2002) . Some of these factors, particularly substance use, are, in turn, associated with depression (Kessler et al., 2003; Sullivan et al., 2008; Williams et al., 2007) , and many studies have failed to adjust for these confounding factors in the relationship between HCV infection and depression. We conducted this study to examine the associations between HCV, somatic symptoms, and depression in a large cohort of HIV-infected patients in clinical care. We hypothesized that HCV would be associated with increased depression *Corresponding author. Email: hcrane@u.washington.edu Care Vol. 23, No. 10, October 2011 symptoms even after accounting for substance use and when measurement of depression did not include somatic symptoms such as fatigue that can be associated with both depression and HCV.
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Methods
Study setting
This cross-sectional study was conducted on a convenience sample of patients from the University of Washington (UW) HIV cohort (Crane et al., 2007; Kitahata et al., 2003) . This study received Institutional Review Board approval.
Study participants
HIV-infected patients older than 18 years of age who attended the clinic for a routine appointment between 15 October 2005 and 11 May 2009 were eligible for the study. Patients receiving interferon were excluded given the well-known effect of interferon on depressive symptoms.
Data sources
As previously described (Crane et al., 2007) , patients used touch-screen tablet PCs to complete assessments of depression symptoms (patient health questionnaire-9 [PHQ-9] from the Primary Care Evaluation of Mental Disorders [PRIME-MD]) (Kroenke, Spitzer, & Williams, 2001; Spitzer, Kroenke, & Williams, 1999) , substance use (Alcohol, Smoking, and Substance Involvement Screening Test [ASSIST]) (Newcombe, Humeniuk, & Ali, 2005) , alcohol risk (Alcohol Use Disorders Identification Test consumption questions [AUDIT-C]) (Bradley et al., 2003; Bush, Kivlahan, McDonell, Fihn, & Bradley, 1998) , health-related quality of life (HRQL) (EuroQOL 5dimension questionnaire [EQ-5D]) Johnson, Coons, Ergo, & Szava-Kovats, 1998; Wu et al., 2002) , and symptoms (HIV Symptom Index) (Justice et al., 2001) .
Clinical data were obtained from the UW HIV Information System (UWHIS), a comprehensive database based on the electronic health records of patients belonging to the UW HIV cohort. It includes clinical data from all outpatient and inpatient encounters including demographic, clinical, laboratory, medication, and socioeconomic information.
HCV
Patients with positive HCV antibody, RNA, or genotype tests were considered HCV coinfected.
Instrument scoring
Standard PHQ-9 scores range from 0 to 27 and are categorized as none (0Á4 points), mild (5Á9 points), moderate (10Á14 points), moderately severe (15Á19), and severe (]20 points) depressive symptom severity (Kroenke et al., 2001) . PHQ-9 standard scores have curvilinear measurement properties with respect to the latent trait of depression defined by all the items, meaning that a constant difference in score implies different amounts of depression symptom severity at different depression severity levels (Crane et al., 2010) . In this situation, using continuous standard total scores in regressions can lead to confusing and even biased findings (Crane et al., 2008) . We therefore generated scores using item response theory (IRT) as done previously (Crane et al., 2010) ; we refer to these throughout as ''depression severity scores.'' IRT-based depression severity scores have linear scaling properties with respect to the latent trait of depression defined by all the items (Embretson & Reise, 2000) . To improve comprehensibility, we transformed depression severity scores by multiplying by 15 and adding 100; this results in rescaling scores analogous to the IQ metric. We plotted a scatter plot showing the relationships between standard PHQ-9 scores and IRT-based depression severity scores.
Previously, we found notable differences in mean depression scores between African-Americans and whites due to item-level bias, referred to as differential item functioning (DIF) (Crane et al., 2010) . We therefore used demographic-specific item parameters to generate scores accounting for DIF related to age, race (African-American vs. white), sex, and HIV transmission risk factor; for this analysis, we omitted individuals who were neither African-American nor white.
Many prior studies used depression measures that include somatic depression symptoms such as fatigue and sleep disturbance that may be impacted by chronic illnesses such as HCV (Dwight et al., 2000; Golub et al., 2004; Hilsabeck, Hassanein, & Perry, 2005; Lang et al., 2006; McDonald, Jayasuriya, Bindley, Gonsalvez, & Gluseska, 2002; Perkins et al., 1995; Poynard et al., 2002; Sullivan & Dworkin, 2003; Tsao, Dobalian, Moreau, & Dobalian, 2004) . This raises the question of whether associations between HCV and depression may be due in part to somatic symptoms associated with HCV rather than depression itself. We thus conducted a sensitivity analysis using a reduced depression severity score in which we removed fatigue, loss of appetite, and sleep disturbance items from the depression instrument. We used IRT to generate this reduced depression score.
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The HIV Symptom Index is a measure of 20 symptom groups (Justice et al., 2001) . Symptom scores were calculated on the basis of number of symptoms patients indicated as bothersome (excluding those symptoms that bothered the patient only a little), with higher scores indicating greater symptom burden. For these analyses, the depression/sadness symptom item was excluded. We also examined symptoms individually, categorizing each symptom as bothersome or not.
There are several ways to score the ASSIST to measure substance use (Newcombe et al., 2005) . We were interested in any illicit drug use, current use defined as taking any illicit drug within the prior three months, and identifying individual substance categories (opiates, amphetamine, or cocaine/crack).
The AUDIT-C scores for alcohol use were calculated by summing the scores for each AUDIT-C question (0Á4 points each) (Bush et al., 1998) . We used a score of ]5 for men and ]4 for women to define at-risk alcohol use (Gual, Segura, Contel, Heather, & Colom, 2002) .
The EQ-5D is a five-item measure of HRQL. The combination of responses categorizes patients into 1 of 243 unique possible health states. Each health state is assigned a preference-based index score using general population-based weights (Shaw, Johnson, & Coons, 2005) .
Statistical analyses
We performed bivariate analyses comparing study participants' characteristics to the entire UW HIV cohort using x 2 tests for categorical variables and t-tests for continuous variables. We compared demographic and clinical characteristics by HCV status using x 2 tests. We performed bivariate analyses of associations with depression severity scores using t-tests. To prevent overestimation of the prevalence of symptoms and behaviors, missing symptom or behavior items were assumed to be absent. We used an imputed height based on age, sex, and race for 15 individuals for whom the height data were missing. We calculated body mass index (BMI) using the traditional Quetelet index (National Heart, Lung, and Blood Institute, 1998). Baseline BMI was categorized as underweight (B18.5 kg/m 2 ), normal (18.5Á 24.9 kg/m 2 ), overweight (25Á29.9 kg/m 2 ), and obese (]30 kg/m 2 ).
Key variables included depression severity scores, HCV infection, demographic characteristics (age, self-reported race/ethnicity, sex, and risk factor for HIV transmission), symptoms, and clinical characteristics (CD4 ' cell count nadir, current CD4 ' cell count, peak HIV-1 RNA level, current antiretroviral therapy [ART] use, current antidepressant medication use, at-risk alcohol use, any or current illicit drug use, and BMI). We used multivariate linear regression to examine the relationship between depression severity scores and HCV infection accounting for demographic and clinical characteristics.
In addition to the main models, we conducted a number of sensitivity analyses. We hypothesized that the effect of HCV on depression severity scores may be mediated, in part, through somatic depression symptoms and therefore excluded them from the main models. However, somatic symptoms including those not typically considered part of the construct of depression were included as covariates in models for sensitivity analyses as comparisons of these results with the main models can help determine the extent to which any relationship between HCV and depression may be mediated by somatic symptoms. To further explore the potential mediating relationship of symptoms, we also conducted adjusted analyses of symptoms and depressive severity scores excluding HCV, and we conducted multivariate logistic regression analyses of HCV and individual symptoms. We constructed depression severity models that adjusted for HRQL scores. We conducted sensitivity analyses using depression severity scores adjusted for item-level bias. We conducted sensitivity analyses using standard PHQ-9 depression severity scores as the outcome. We conducted analyses using standard PHQ-9 depression severity categories defined by standard scores as the outcome; these models employed ordinal logistic regression. Two-tailed p values of B0.05 were considered significant for statistical tests. Analyses were conducted using Stata 9.2 (StataCorp).
Results
During the study period, the assessment was completed by 764 eligible HIV-infected patients of whom 160 (21%) had HCV infection (see Table 1 ). One patient receiving pegylated interferon therapy was excluded from the study. Completion rates were high with minimal missing data. Missing data rates for each symptom item were all B3%, with the highest rate for the nausea item (missing for 19/764, 2.5%). There were 28 patients who had missing data for the AUDIT-C (3.7%) and 44 patients who had missing data for any of the items for the EuroQOL (5.6%). The median age was 45 years, 87% were men, the median current CD4 ' T cell count was 393 cells/mm 3 , and the mean BMI was 26.6 kg/m 2 (SD 0 5.0). At the time of the assessment, 172 patients (23%) were receiving antidepressant medications. Demographic and clinical characteristics of study patients were similar to those HCV-infected patients were more likely to have lower nadir CD4 ' cell counts (382 vs. 433 cells/mm 3 , p00.01), to have been injection drug users (p B0.001), and to report current illicit drug use within the past three months (p B 0.001). HCV-infected patients were more likely to report ever use and current use of cocaine, amphetamines, or opiates compared with those without HCV (p values all B0.001). HCVinfected patients were also more often prescribed antidepressant medication (p 00.03). There were no significant differences between those with HCV infection and those without in regard to sex, age, race/ ethnicity, at-risk alcohol use, BMI, current CD4 ' count, and peak HIV viral load (Table 1) .
We found a high overall symptom burden, with patients reporting an average of 4.1 symptoms (SD 04.2). Fatigue (43%) and sleep disturbance (34%) were the most common symptoms endorsed (Figure 1) . HCV-infected patients had a higher symptom burden on average than those without HCV, with a symptom score of 4.8 vs. 3.9 (p 00.02).
The curvilinear relationship between IRT depression severity scores and standard scores is shown in the scatter plot ( Figure 2) . Two hundred and ninety patients (38%) had no depression, 208 (27%) had mild depression, 126 (17%) had moderate depression, 82 (11%) had moderately severe depression, and 58 (8%) had severe depression defined by standard scores (Kroenke et al., 2001 ). Among HCV-infected patients, 73 (46%) were at least moderately depressed, compared with 193 (32%) of those without HCV (p 0 0.001) (Table 1) , and mean depression severity scores were higher in HCV-infected patients (102 vs. 98, p 00.002).
Multivariate linear regression analyses suggested that HCV infection was associated with higher depression severity scores when controlling for differences in age, sex, race, CD4 ' count nadir, current CD4 ' count, ART status, current illicit drug use, at-risk alcohol use, and BMI. Mean depression severity scores for HCV-infected patients were 3.4 points higher than for patients without HCV in adjusted analyses (Table 2 ). In addition, higher BMI, current illicit drug use, and at-risk alcohol use were associated with higher depression severity scores. The association between HCV and greater depression severity remained significant in models that also adjusted for antidepressant medication use ('2.9, p 0 0.02), and in models that also adjusted for any rather than current illicit drug use ('3.4, p 00.01), or both any and current illicit drug use ('2.9, p 0 0.03). Findings were similar in sensitivity analyses using standard PHQ-9 scores and in sensitivity analyses using IRT scores that accounted for DIF rather than naive IRT scores (data not shown).
HCV infection was associated with more severe depression severity category in sensitivity analyses using ordinal logistic regression with standard PHQ-9 score-based depression symptom severity categories (Kroenke et al., 2001) (Table 3) . HCV infection remained associated with more severe depression in multivariate analyses using reduced depression severity scores constructed from the six nonsomatic PHQ-9 items ('3.1, p 00.01).
To examine whether somatic symptoms including symptoms not typically considered part of the depression construct could potentially be mediating the association between HCV and depression severity scores using a classic approach (Figure 3) (Baron & Kenny, 1986) , we first demonstrated that HCV was associated with overall symptom burden scores (p 00.04) in adjusted analyses. Furthermore, HCV was also associated with a number of individual symptoms particularly memory problems, poor appetite, and nausea (p 00.006Á0.03). We then demonstrated in adjusted models without HCV that higher overall symptom burden was associated with more severe depression severity scores (p B0.001). In models with individual symptoms rather than overall symptom burden, memory problems, poor appetite, fatigue, fevers, anxiety, sleep disturbance, sexual dysfunction, and weight loss were all associated with more severe depression symptom severity Figure 2 . Scatter plot and lowess curve of IRT depression scores with standard PHQ-9 scores. Note: This graph shows the range of depression levels associated with each standard PHQ-9 score in the scatter plot with gray dots. Depression severity categories based on standard PHQ-9 scores are also shown. In IRT scoring, unlike standard scoring, items may receive unequal weight. Endorsing a particular frequency of a more severe depression symptom results in a higher depression severity score than endorsing the same frequency of a less severe depression symptom. For example, consider individuals with standard PHQ-9 scores of 15 (the bottom row of the ''Moderately severe'' category). IRT depression severity scores for these individuals range from 107 to 116, suggesting some variability in the severity of depression masked by equal weights applied to each item in the standard PHQ-9 scores. The range of IRT depression severity scores associated with each standard PHQ-9 scores varies from a single value (at the minimal and maximal values of 0 and 27 points) to a 10-point range (at standard scores of seven points). The 10point range represents two-third of a standard deviation.
The black lowess curve shows a curvilinear relationship between standard scores and the level of depression. For these reasons, we chose to use the IRT depression score rather than the standard PHQ-9 score in our regression analyses. AIDS Care 1213 (pB0.001Á0.007). Finally, we examined the association between HCV and depression severity scores in adjusted models that included individual somatic symptoms or overall symptom burden scores. When somatic symptoms were included as individual covariates or as overall symptom burden, HCV infection was no longer significantly associated with higher depression severity scores (p 00.09Á0.1). Fatigue, subjective fevers, memory problems, anxiety, decreased appetite, sleep disturbance, sexual dysfunction, and weight loss were significantly associated with depression severity scores in adjusted models that included all symptoms. Depression severity scores constructed from the six nonsomatic PHQ-9 items were associated with the same symptoms. Nausea, dizziness, and musculoskeletal pains were not associated with depression severity and were dropped from subsequent analyses. The mean EuroQOL score for the entire study cohort was 0.80 (SD 0 0.19). HCV-infected patients had worse HRQL, with mean EuroQOL score of 0.76 in HCV-infected patients vs. 0.81 in patients without HCV infection (p 00.01). After accounting for clinical and demographic characteristics (age, race, sex, recent illicit drug use, nadir and recent CD4 ' counts, and ART status), the association between HCV infection and HRQL was no longer significant (p 00.07).
Discussion
We found a high prevalence and severity of depression among HIV-infected patients in routine care, particularly among those coinfected with HCV. The association between HCV and depression severity persisted when omitting somatic depression symptom items from the depression measure. However, the association was not seen in adjusted analyses that included somatic symptoms as covariates. Increased BMI, current illicit drug use, and at-risk alcohol use were also consistently associated with greater depression severity.
HCV infection is associated with depression in those without HIV infection (el-Serag, Kunik, Richardson, & Rabeneck, 2002; Gallegos-Orozco et al., 2003; Goulding, O'Connell, & Murray, 2001; Johnson, Fisher, Fenaughty, & Theno, 1998; Lim, Cronkite, Goldstein, & Cheung, 2006; Obhrai, Hall, & Anand, 2001; Singh, Gayowski, Wagener, & Marino, 1997) . However, there are conflicting data regarding the association between HCV and depression in HIV-infected patients (Backus et al., 2005; Baillargeon et al., 2008; Baum et al., 2008; Grassi et al., 2002; Libman et al., 2006; Mrus et al., 2006; Richardson et al., 2005; von Giesen et al., 2004) . Our study supports an association between HCV and greater depression severity. Our conclusions are robust to several scoring methods including IRT estimates of depression severity from the whole scale and the nonsomatic items, and depression categories and continuous scores defined using standard scoring. Furthermore, despite high prevalence rates of depression among patients with substance use issues, and a high prevalence of substance use among patients with HCV, we found that the association between HCV and greater depression severity persisted in numerous Note: This figure is modified from Baron and Kenny (1986) .
sensitivity analyses adjusting for current substance use, past substance use, or both. Somatic symptoms such as fatigue and sleep disturbance may be due to depression as well as due to chronic illnesses including HIV or HCV infection, thereby obscuring examination of associations between HCV infection and depression (McDonald et al., 2002; Perkins et al., 1995; Sullivan & Dworkin, 2003; Tsao et al., 2004) . Studies have suggested that depression associated with HCV infection in HIVinfected patients may be attributable to somatic symptoms such as fatigue. For example, Braitstein and colleagues and Clifford and colleagues found that HIV-infected patients with HCV had higher Center for Epidemiological Studies Depression Scale (CES-D) somatic scores than those with HIV without HCV infection (Braitstein et al., 2005; Clifford, Evans, Yang, & Gulick, 2005) . In our analyses, including or excluding the somatic depression symptom items in IRT depression severity scores did not substantially impact the strength of association between HCV and depression. This suggests that the association between HCV and depression is not simply due to the patients meeting the clinical criteria for depression due to HCV-related somatic symptoms. Nevertheless, this finding does not exclude the possibility that HCV-related symptoms may be on a causal pathway leading to depression.
To further understand the potential role of somatic symptoms in possibly mediating the relationship between HCV and depression among HIV-infected patients, we examined the association between HCV and depression severity in models that included indicators for overall symptom burden or individual symptoms including those not considered part of the depression construct. In these models, there was no longer an association between HCV and depression, suggesting that HCV-related somatic symptoms may mediate the relationship between HCV infection and depressive symptom severity. It may be that somatic symptoms associated with HCV cause depression. Alternatively, depressed patients may have a heightened awareness of symptoms due to their depression and the association of HCV and depression may in part be mediated by other factors. Only longitudinal studies can distinguish between these alternative explanations.
Potential limitations of our study include the reliance on self-reported data for some variables and the use of a convenience sample of patients who completed the assessment, although our sample's demographic and clinical characteristics were similar to the entire cohort. In addition, the PHQ-9 questionnaire was not designed as a diagnostic tool although its validity has been evaluated previously, demonstrating good agreement with diagnoses made by mental health professionals (Spitzer et al., 1994; . HCV-coinfected patients could have been misclassified because of false-negative HCV antibody test results or positive test results despite spontaneous HCV clearance. Negative HCV antibody test results among HCV-coinfected patients occur; however, it is uncommon (Forns & Costa, 2006) , and spontaneous HCV clearance rates are lower among those with HIV than among the general population (Grebely et al., 2007) . Furthermore, 139 of the 160 patients had a positive HCV RNA test result. The cross-sectional nature of the study limits our ability to infer causal relationships in the association between HCV and depression. In addition, patients were recruited from a single large HIV clinic, so our findings may not be generalizable to all HIV-infected patients, especially those not in care.
Strengths of our study include the relatively large and diverse study population and standardized depression assessment. In addition, comprehensive clinical data facilitated adjustment for key potential confounding factors such as current and past illicit drug use, at-risk alcohol use, CD4 ' cell count nadir, and current ART use. Furthermore, unlike some previous studies (12, 22, 46, 63) (Golden, O'Dwyer, & Conroy, 2005; Thein et al., 2007) , we avoided possible selection bias related to recruitment of patients from treatment trials, which tend to exclude patients with ongoing drug use or mental illness or include patients with only more severe HCV disease.
Conclusions
In summary, we found high rates of depression in HIV-infected patients in routine care, particularly among those with HCV infection. The association between HCV and greater depression severity persisted even after taking into account associations between past or current substance use and depression severity. These findings suggest that there is an independent association between HCV and depression severity above and beyond any associations due to substance use. The association between HCV and depression persisted even when the depression measure excluded somatic items, suggesting that this association is not due to a misattribution of HCVrelated somatic complaints toward the diagnosis of depression. Providers should be alert to the high rates of depression among HIV-infected patients in routine clinical care, particularly among those with HCV. Further longitudinal studies are needed to determine the casual role of HCV and HCV-related somatic symptoms in the development of depression.
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